… The proposed utility of neo-adjuvant chemotherapy in inoperable primary thyroid cancer
and loco-regional control in DTC were presented in a non-randomized, retrospective trial by …

… Moreover, thyroid cancer is more frequent in women under 25 years of age and in those
aged between 45 and 60 years [1]. Luckily, DTC has a slow and non-aggressive course in most …

… prognostic utility of liquid biopsy has been proven in the more aggressive MTC and ATC [23]
[24]. Further understanding of the tumoral DNA natural history can refine the clinical utility of …

… To illustrate the impact of age and utility of the nomogram designed for this study, we present
a hypothetical patient with MTC. A 71-year old non-Hispanic white female with a T3N1M0 …

… thyroid surgery, the utility of prophylactic and therapeutic lymph node dissection, and
evidence-based guidelines in the treatment of differentiated thyroid cancers… utility of this …

… In this approach, the best prognostic utility of the genetic markers in guiding the treatment
of thyroid cancer can be achieved in a clinical risk level-based and genotype-individualized …

… Differentiated thyroid cancer is the most common … thyroid cancer has invited debate about
the appropriate management strategy for such patients, particularly those with papillary thyroid …

… For example, if one adds to the TNM stages for thyroid cancer age information (two groups:
… Because the primary utility of the TNM staging system is its simplicity as a “look-up” table in …

… From the comprehensive analysis, we focused on the clinical utility of immune landscape
on prognostic stratification and potential implication as a biomarker reflecting immune …

… TIME-related prognostic model to … utility of the nomogram versus the risk score model in
the BRAF-mutated PTC cohort. Moreover, we determined the associations between prognostic …